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Abstract –
Bartonella bacilliformis is a human bacterial pathogen and
the etiological agent of Carrión’s Disease. B. bacilliformis is
serum-resistant, allowing it to survive in the human
bloodstream and persist and replicate in erythrocytes.
Human factor H is a circulating protein in human blood that
is part of the complement cascade of innate immune
defense. Factor H binds to self-cells and prevents auto-
immunity by complement fixation. A Far-Western blot
followed by mass spectrometry analysis suggests that
several B. bacilliformis proteins can bind to human Factor H.
Here, we describe one protein, BB1133; an outer membrane
auto-transporter and the Factor H-binding protein identified
by mass spectrometry. Two distinct domains of BB1133
were cloned and expressed in E. coli using the Gateway
cloning system and pET-DEST42 vector. IPTG induction of
the constructs, followed by a Far-Western blot with human
Factor H as a probe, shows that the passenger domain of
BB1133 is responsible for binding human factor H.
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Fig. 1: SDS-PAGE (left) and 
corresponding FW blot (right)
showing four B. bacilliformis
membrane proteins that bind 
human fH (far right). MALDI-TOF 
MS was used to identify the 
arrowed protein as Bb1133.
Fig. 2: Phyre2 3D Protein Model of Bb1133. The 
yellow section is the predicted passenger domain (PD), 
the green portion is the autotransporter (AUTO), and 
the red filament is the stalk. (Adapted from [2])
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Results and Discussion –
§ Subcloning of two Bb1133 domains into pEXP42, 
expression in E. coli and FW blots demonstrate that 
the PD of Bb1133 is responsible for binding human fH 
and is therefore likely used by the pathogen to avoid 
destruction by human complement during infection.
Background –
§ B. bacilliformis is the etiological agent of Carrión’s disease, 
a vector-borne disease transmitted to humans via 
phlebotomine sand flies.
§ Bb1133 is a trimeric autotransporter adhesin (TAA) protein. 
TAA’s are Gram-negative outer membrane (OM) proteins 
[1], secreted by the bacterium, and are comprised of two 
parts: the autotransporter and the passenger domain. The 
passenger domain is the portion of TAAs responsible for 
binding host ligands.
§ Factor H (fH) is a part of the complement cascade of the 
innate human immune system. fH binds to self-cells and 
prevents them from being destroyed by immune activities 
of complement fixation.
§ B. bacilliformis binds human fH, and we hypothesize that 
this allows the pathogen to resist complement and persist 
in the blood stream. 
Fig. 4: Plasmid Maps of Subclones. A) Bb1133 PD cloned 
into pEXP42 plasmid. B) Bb1133 AUTO cloned into pEXP42 
plasmid.
Fig. 3: Trimeric 
Autotransporter Adhesin 
(TAA) Domains. Typical 
domains of TAAs are 
shown. AUTO and PD 
portions of Bb1133 were 
subcloned since intact 
Bb1133 was toxic to E. 
coli. (Figure modified from 
[1]).
Future Directions –
§ Knockout Bb1133 in Bartonella bacilliformis.
§ Check for fH binding using FW blots in mutated
Bartonella bacilliformis
§ Determine whether complement resistance is
impaired in mutant versus wild-type strains.
Aims -
§ Identify Bb1133 autotransporter (AUTO) and passenger (PD) 
domains (Fig. 3)
§ Clone Bb1133 AUTO and PD into E. Coli pEXP42 plasmid 
vectors (Fig. 4)
§ Verify His-tag expression in pEXP42 AUTO and PD via a 
HisHRP Far-Western (FW) blots (Fig. 5)
§ Identify whether AUTO or PD are fH-binding via fH FW blots 
(Fig. 6)
Fig. 5: HisHRP (Nickel-Activated Horseradish 
Peroxidase) FW Blot. Blot (with corresponding 
Coomassie SDS-PAGE gel on left) indicates that the His-
tag is detectable in both pEXP42AUTO and pEXP42PD. 
Both recombinant proteins are in the insoluble fraction of 
the bacterial cell. The PD was broken into several 
fragments with His-tags (lane 7).
Fig. 6: FW Blot showing that the PD of Bb1133 is 
responsible for binding human fH. Recombinant PD 
bands of 70 and 85 kDa bind fH. [The 85-kDa band is the 
full-length PD of Bb1133]. The FW blot corresponds to 
the Coomassie blue SDS-PAGE gel shown in Fig. 5. 
Models of passenger domain translocation across the OM. (A) Protein with folded β-barrel and 
inserted into the OM, before translocation and folding of the passenger domain. 
Kornelia M. Mikula et al. J. Bacteriol. 2012;194:827-838
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Factor	H	Far	western
HisHRP and	Factor	H	Far	westerns	of	induction	of	pEXP42PD	(passenger	domain)	and	pEXP42AT	
(autotransporter)	soluble	and	insoluble	factions	from	Bb1133.	[30ug	protein/lane]
Factor	H	Far	western:	Block	o/n-PBST*+5%milk.	1h	5ug/ul pooled	human	Complement	FH	in	PBST.	1h	mouse	anti-
human	FH	(1:1000)	in	PBST.	Wash	3X,	5min	PBST.	1h	rabbit	anti-mouse	peroxidase	(1:40,000)	in	PBST.	Wash	3X,	5min	
PBST.	Develop	with	ECL	Pico	Chemiluminence.	(*PBST-1XPBS	pH	7.4+0.3%	Tween-20)
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